226 related articles for article (PubMed ID: 20153804)
1. Pituitary senescence: the evolving role of Pttg.
Chesnokova V; Melmed S
Mol Cell Endocrinol; 2010 Sep; 326(1-2):55-9. PubMed ID: 20153804
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of pituitary adenoma senescence.
Chesnokova V; Zonis S; Ben-Shlomo A; Wawrowsky K; Melmed S
Front Horm Res; 2010; 38():7-14. PubMed ID: 20616490
[TBL] [Abstract][Full Text] [Related]
3. Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.
Chesnokova V; Zonis S; Rubinek T; Yu R; Ben-Shlomo A; Kovacs K; Wawrowsky K; Melmed S
Cancer Res; 2007 Nov; 67(21):10564-72. PubMed ID: 17975001
[TBL] [Abstract][Full Text] [Related]
4. p21(Cip1) restrains pituitary tumor growth.
Chesnokova V; Zonis S; Kovacs K; Ben-Shlomo A; Wawrowsky K; Bannykh S; Melmed S
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17498-503. PubMed ID: 18981426
[TBL] [Abstract][Full Text] [Related]
5. Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.
Chesnokova V; Zonis S; Wawrowsky K; Tani Y; Ben-Shlomo A; Ljubimov V; Mamelak A; Bannykh S; Melmed S
Mol Endocrinol; 2012 Dec; 26(12):2092-103. PubMed ID: 23051594
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone is a cellular senescence target in pituitary and nonpituitary cells.
Chesnokova V; Zhou C; Ben-Shlomo A; Zonis S; Tani Y; Ren SG; Melmed S
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3331-9. PubMed ID: 23940366
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms Underlying Pituitary Pathogenesis.
Sapochnik M; Nieto LE; Fuertes M; Arzt E
Biochem Genet; 2016 Apr; 54(2):107-19. PubMed ID: 26718581
[TBL] [Abstract][Full Text] [Related]
8. Lineage-specific restraint of pituitary gonadotroph cell adenoma growth.
Chesnokova V; Zonis S; Zhou C; Ben-Shlomo A; Wawrowsky K; Toledano Y; Tong Y; Kovacs K; Scheithauer B; Melmed S
PLoS One; 2011 Mar; 6(3):e17924. PubMed ID: 21464964
[TBL] [Abstract][Full Text] [Related]
9. Oncogene activation in pituitary tumors.
Yu R; Melmed S
Brain Pathol; 2001 Jul; 11(3):328-41. PubMed ID: 11414475
[TBL] [Abstract][Full Text] [Related]
10. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.
Ozkaya HM; Comunoglu N; Keskin FE; Oz B; Haliloglu OA; Tanriover N; Gazioglu N; Kadioglu P
Endocrine; 2016 Jun; 52(3):632-40. PubMed ID: 26578364
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of pituitary tumor transforming gene in tumorigenesis.
Tfelt-Hansen J; Kanuparthi D; Chattopadhyay N
Clin Med Res; 2006 Jun; 4(2):130-7. PubMed ID: 16809406
[TBL] [Abstract][Full Text] [Related]
12. Diminished pancreatic beta-cell mass in securin-null mice is caused by beta-cell apoptosis and senescence.
Chesnokova V; Wong C; Zonis S; Gruszka A; Wawrowsky K; Ren SG; Benshlomo A; Yu R
Endocrinology; 2009 Jun; 150(6):2603-10. PubMed ID: 19213844
[TBL] [Abstract][Full Text] [Related]
13. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas.
Hunter JA; Skelly RH; Aylwin SJ; Geddes JF; Evanson J; Besser GM; Monson JP; Burrin JM
Eur J Endocrinol; 2003 Feb; 148(2):203-11. PubMed ID: 12590639
[TBL] [Abstract][Full Text] [Related]
14. PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines.
Minematsu T; Egashira N; Kajiya H; Takei M; Takekoshi S; Itoh Y; Tsukamoto H; Itoh J; Sanno N; Teramoto A; Osamura RY
Endocr Pathol; 2007; 18(1):8-15. PubMed ID: 17652795
[TBL] [Abstract][Full Text] [Related]
15. Functional role of estrogen in pituitary tumor pathogenesis.
Heaney AP; Fernando M; Melmed S
J Clin Invest; 2002 Jan; 109(2):277-83. PubMed ID: 11805140
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumour-transforming gene (PTTG) and pituitary senescence.
Chesnokova V; Melmed S
Horm Res; 2009 Apr; 71 Suppl 2():82-7. PubMed ID: 19407503
[TBL] [Abstract][Full Text] [Related]
17. Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicity.
Fuertes M; Sapochnik M; Tedesco L; Senin S; Attorresi A; Ajler P; Carrizo G; Cervio A; Sevlever G; Bonfiglio JJ; Stalla GK; Arzt E
Endocr Relat Cancer; 2018 Jun; 25(6):665-676. PubMed ID: 29622689
[TBL] [Abstract][Full Text] [Related]
18. DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.
Ben-Shlomo A; Deng N; Ding E; Yamamoto M; Mamelak A; Chesnokova V; Labadzhyan A; Melmed S
J Clin Invest; 2020 Nov; 130(11):5738-5755. PubMed ID: 32673291
[TBL] [Abstract][Full Text] [Related]
19. PTTG has a Dual Role of Promotion-Inhibition in the Development of Pituitary Adenomas.
Xiong Z; Li X; Yang Q
Protein Pept Lett; 2019; 26(11):800-818. PubMed ID: 37020362
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
